Evidence map›Paper›PMID 38467710›Full record

ArticleNPJ digital medicine2024

Modeling multiple sclerosis using mobile and wearable sensor data.

Shkurta Gashi, Pietro Oldrati, Max Moebus, Marc Hilty, Liliana Barrios, Firat Ozdemir, PHRT Consortium, Veronika Kana, Andreas Lutterotti, Gunnar Rätsch and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in NPJ digital medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07783074 (Fatigue Investigation Using Digital Outcomes), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07783074 recruitingnot on this mapstarted 2026, after this paper: background citation

Fatigue Investigation Using Digital Outcomes (FIDO) - An Exploratory Project

TypeobservationalSponsorLiliana BarriosRan2026 to 2028Enrolled122ConditionsMultiple Sclerosis, Long Covid, Healthy
3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Digital signatures of fatigue and wearing-off symptoms in patients with multiple sclerosis under natalizumab.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Digital Activity Markers in Chronic Inflammatory Demyelinating Polyneuropathy.Annals of clinical and translational neurology · 2025
    Observational
  12. Decreased Heart Rate Variability Is Associated with Increased Fatigue Across Different Medical Populations: A Systematic Review.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shkurta GashiDepartment of Computer Science, ETH Zürich, Zürich, Switzerland. shkurta.gashi@ai.ethz.ch.ORCID http://orcid.org/0000-0001-6650-3784
Pietro OldratiInstitute for Implementation Science in Health Care, University of Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0001-5551-4306
Max MoebusDepartment of Computer Science, ETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-3414-7142
Marc HiltyDepartment of Neurology, University Hospital Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-8454-531X
Liliana BarriosDepartment of Computer Science, ETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-4953-5335
Firat OzdemirSwiss Data Science Center, ETH Zürich & EPFL, Zürich, Switzerland.ORCID http://orcid.org/0000-0001-6643-7318
PHRT Consortium
Veronika KanaDepartment of Neurology, University Hospital Zürich, Zürich, Switzerland.
Andreas LutterottiDepartment of Neurology, University Hospital Zürich, Zürich, Switzerland.
Gunnar RätschDepartment of Computer Science, ETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0001-5486-8532
Christian HolzDepartment of Computer Science, ETH Zürich, Zürich, Switzerland.ORCID http://orcid.org/0000-0001-9655-9519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple sclerosis (MS) is a neurological disease of the central nervous system that is the leading cause of non-traumatic disability in young adults. Clinical laboratory tests and neuroimaging studies are the standard methods to diagnose and monitor MS. However, due to infrequent clinic visits, it is fundamental to identify remote and frequent approaches for monitoring MS, which enable timely diagnosis, early access to treatment, and slowing down disease progression. In this work, we investigate the most reliable, clinically useful, and available features derived from mobile and wearable devices as well as their ability to distinguish people with MS (PwMS) from healthy controls, recognize MS disability and fatigue levels. To this end, we formalize clinical knowledge and derive behavioral markers to characterize MS. We evaluate our approach on a dataset we collected from 55 PwMS and 24 healthy controls for a total of 489 days conducted in free-living conditions. The dataset contains wearable sensor data - e.g., heart rate - collected using an arm-worn device, smartphone data - e.g., phone locks - collected through a mobile application, patient health records - e.g., MS type - obtained from the hospital, and self-reports - e.g., fatigue level - collected using validated questionnaires administered via the mobile application. Our results demonstrate the feasibility of using features derived from mobile and wearable sensors to monitor MS. Our findings open up opportunities for continuous monitoring of MS in free-living conditions and can be used to evaluate and guide the effectiveness of treatments, manage the disease, and identify participants for clinical trials.

Identifiers

PMID38467710
PMCPMC10928076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.